15. MARKET SIZING AND OPPORTUNITY ANALYSIS
15.1. Chapter Overview
15.2. Forecast Methodology
15.3. Overall Biologics Fill / Finish Services Market, 2021-2030
15.3.1. Biologics Fill / Finish Services Market, 2021-2030: Distribution by Type of Packaging
15.3.2. Biologics Fill / Finish Services Market, 2021-2030: Distribution by Scale of Operation
15.3.3. Biologics Fill / Finish Services Market, 2021-2030: Distribution by Type of Biologic
15.3.4. Biologics Fill / Finish Services Market, 2021-2030: Distribution by Therapeutic Area
15.3.5. Biologics Fill / Finish Services Market, 2021-2030: Distribution by Geographical Region
15.3.5.1 Biologics Fill / Finish Services Market in North America, 2021-2030: Distribution by Countries
15.3.5.2. Biologics Fill / Finish Services Market in North America, 2021-2030: Distribution by Type of Packaging
15.3.5.3. Biologics Fill / Finish Services Market in North America, 2021-2030: Distribution by Scale of Operation
15.3.5.4. Biologics Fill / Finish Services Market in North America, 2021-2030: Distribution by Type of Biologic
15.3.5.5. Biologics Fill / Finish Services Market in North America, 2021-2030: Distribution by Therapeutic Area
15.3.5.6. Biologics Fill / Finish Services Market in Europe, 2021-2030: Distribution by Countries
15.3.5.7. Biologics Fill / Finish Services Market in Europe, 2021-2030: Distribution by Type of Packaging
15.3.5.8. Biologics Fill / Finish Services Market in Europe, 2021-2030: Distribution by Scale of Operation
15.3.5.9. Biologics Fill / Finish Services Market in Europe, 2021-2030: Distribution by Type of Biologic
15.3.5.10. Biologics Fill / Finish Services Market in Europe, 2021-2030: Distribution by Therapeutic Area
15.3.5.11. Biologics Fill / Finish Services Market in Asia-Pacific, 2021-2030: Distribution by Countries
15.3.5.12. Biologics Fill / Finish Services Market in Asia-Pacific, 2021-2030: Distribution by Type of Packaging
15.3.5.13. Biologics Fill / Finish Services Market in Asia-Pacific, 2021-2030: Distribution by Scale of Operation
15.3.5.14. Biologics Fill / Finish Services Market in Asia-Pacific, 2021-2030: Distribution by Type of Biologic
15.3.5.15. Biologics Fill / Finish Services Market in Asia-Pacific, 2021-2030: Distribution by Therapeutic Area
15.4. Biologics Fill / Finish Services Market for Ampoules, 2021-2030
15.4.1. Biologics Fill / Finish Services Market for Ampoules, 2021-2030: Distribution by Scale of Operation
15.4.2. Biologics Fill / Finish Services Market for Ampoules, 2021-2030: Distribution by Type of Biologic
15.4.3. Biologics Fill / Finish Services Market for Ampoules, 2021-2030: Distribution by Therapeutic Area
15.4.4. Biologics Fill / Finish Services Market for Ampoules, 2021-2030: Distribution by Geographical Region
15.4.4.1. Biologics Fill / Finish Services Market for Ampoules in North America, 2021-2030: Distribution by Scale of Operation
15.4.4.2. Biologics Fill / Finish Services Market for Ampoules in North America, 2021-2030: Distribution by Type of Biologic
15.4.4.3. Biologics Fill / Finish Services Market for Ampoules in North America, 2021-2030: Distribution by Therapeutic Area
15.4.4.4. Biologics Fill / Finish Services Market for Ampoules in Europe, 2021-2030: Distribution by Scale of Operation
15.4.4.5. Biologics Fill / Finish Services Market for Ampoules in Europe, 2021-2030: Distribution by Type of Biologic
15.4.4.6. Biologics Fill / Finish Services Market for Ampoules in Europe, 2021-2030: Distribution by Therapeutic Area
15.4.4.7. Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, 2021-2030: Distribution by Scale of Operation
15.4.4.8. Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, 2021-2030: Distribution by Type of Biologic
15.4.4.9. Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, 2021-2030: Distribution by Therapeutic Area
15.5. Biologics Fill / Finish Services Market for Cartridges, 2021-2030
15.5.1. Biologics Fill / Finish Services Market for Cartridges, 2021-2030: Distribution by Scale of Operation
15.5.2. Biologics Fill / Finish Services Market for Cartridges, 2021-2030: Distribution by Type of Biologic
15.5.3. Biologics Fill / Finish Services Market for Cartridges, 2021-2030: Distribution by Therapeutic Area
15.5.4. Biologics Fill / Finish Services Market for Cartridges, 2021-2030: Distribution by Geographical Region
15.5.4.1. Biologics Fill / Finish Services Market for Cartridges in North America, 2021-2030: Distribution by Scale of Operation
15.5.4.2. Biologics Fill / Finish Services Market for Cartridges in North America, 2021-2030: Distribution by Type of Biologic
15.5.4.3. Biologics Fill / Finish Services Market for Cartridges in North America, 2021-2030: Distribution by Therapeutic Area
15.5.4.4. Biologics Fill / Finish Services Market for Cartridges in Europe, 2021-2030: Distribution by Scale of Operation
15.5.4.5. Biologics Fill / Finish Services Market for Cartridges in Europe, 2021-2030: Distribution by Type of Biologic
15.5.4.6. Biologics Fill / Finish Services Market for Cartridges in Europe, 2021-2030: Distribution by Therapeutic Area
15.5.4.7. Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, 2021-2030: Distribution by Scale of Operation
15.5.4.8. Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, 2021-2030: Distribution by Type of Biologic
15.5.4.9. Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, 2021-2030: Distribution by Therapeutic Area
15.6. Biologics Fill / Finish Services Market for Syringes, 2021-2030
15.6.1. Biologics Fill / Finish Services Market for Syringes, 2021-2030: Distribution by Scale of Operation
15.6.2. Biologics Fill / Finish Services Market for Syringes, 2021-2030: Distribution by Type of Biologic
15.6.3. Biologics Fill / Finish Services Market for Syringes, 2021-2030: Distribution by Therapeutic Area
15.6.4. Biologics Fill / Finish Services Market for Syringes, 2021-2030: Distribution by Geographical Region
15.6.4.1. Biologics Fill / Finish Services Market for Syringes in North America, 2021-2030: Distribution by Scale of Operation
15.6.4.2. Biologics Fill / Finish Services Market for Syringes in North America, 2021-2030: Distribution by Type of Biologic
15.6.4.3. Biologics Fill / Finish Services Market for Syringes in North America, 2021-2030: Distribution by Therapeutic Area
15.6.4.4. Biologics Fill / Finish Services Market for Syringes in Europe, 2021-2030: Distribution by Scale of Operation
15.6.4.5. Biologics Fill / Finish Services Market for Syringes in Europe, 2021-2030: Distribution by Type of Biologic
15.6.4.6. Biologics Fill / Finish Services Market for Syringes in Europe, 2021-2030: Distribution by Therapeutic Area
15.6.4.7. Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, 2021-2030: Distribution by Scale of Operation
15.6.4.8. Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, 2021-2030: Distribution by Type of Biologic
15.6.4.9. Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, 2021-2030: Distribution by Therapeutic Area
15.7. Biologics Fill / Finish Services Market for Vials, 2021-2030
15.7.1. Biologics Fill / Finish Services Market for Vials, 2021-2030: Distribution by Scale of Operation
15.7.2. Biologics Fill / Finish Services Market for Vials, 2021-2030: Distribution by Type of Biologic
15.7.3. Biologics Fill / Finish Services Market for Vials, 2021-2030: Distribution by Therapeutic Area
15.7.4. Biologics Fill / Finish Services Market for Vials, 2021-2030: Distribution by Geographical Region
15.7.4.1. Biologics Fill / Finish Services Market for Vials in North America, 2021-2030: Distribution by Scale of Operation
15.7.4.2. Biologics Fill / Finish Services Market for Vials in North America, 2021-2030: Distribution by Type of Biologic
15.7.4.3. Biologics Fill / Finish Services Market for Vials in North America, 2021-2030: Distribution by Therapeutic Area
15.7.4.4. Biologics Fill / Finish Services Market for Vials in Europe, 2021-2030: Distribution by Scale of Operation
15.7.4.5. Biologics Fill / Finish Services Market for Vials in Europe, 2021-2030: Distribution by Type of Biologic
15.7.4.6. Biologics Fill / Finish Services Market for Vials in Europe, 2021-2030: Distribution by Therapeutic Area
15.7.4.7. Biologics Fill / Finish Services Market for Vials in Asia-Pacific, 2021-2030: Distribution by Scale of Operation
15.7.4.8. Biologics Fill / Finish Services Market for Vials in Asia-Pacific, 2021-2030: Distribution by Type of Biologic
15.7.4.9. Biologics Fill / Finish Services Market for Vials in Asia-Pacific, 2021-2030: Distribution by Therapeutic Area
List of Figures
Figure 3.1 Various Types of Biologics
Figure 3.2 Types of Third-Party Service Providers
Figure 3.3 Commonly Outsourced Operations
Figure 3.4 Steps Involved in Fill / Finish of Biologics
Figure 3.5 Key Considerations for Selecting a CMO Partner
Figure 3.6 Risks and Challenges of Outsourcing Biologics Fill / Finish Operations
Figure 4.1 Biologics Fill / Finish Service Providers: Distribution by Year of Establishment
Figure 4.2 Biologics Fill / Finish Service Providers: Distribution by Company Size
Figure 4.3 Biologics Fill / Finish Service Providers: Distribution by Location of Headquarters
Figure 4.4 Biologics Fill / Finish Service Providers: Distribution by Location of Fill / Finish Facilities
Figure 4.5 Biologics Fill / Finish Service Providers: Distribution by Type of Packaging
Figure 4.6 Biologics Fill / Finish Service Providers: Distribution by Type of Biologic Involved and Type of Packaging Form
Figure 4.7 Biologics Fill / Finish Service Providers: Distribution by Scale of Operation
Figure 4.8 Biologics Fill / Finish Service Providers: Distribution by Additional Services Offered
Figure 5.1 Company Competitiveness Analysis: Biologics Fill / Finish Service Providers in North America
Figure 5.2 Company Competitiveness Analysis: Players Offering Services in Ampoules (North America)
Figure 5.3 Company Competitiveness Analysis: Players Offering Services in Cartridges (North America)
Figure 5.4 Company Competitiveness Analysis: Players Offering Services in Syringes (North America)
Figure 5.5 Company Competitiveness Analysis: Players Offering Services in Vials (North America)
Figure 5.6 Company Competitiveness Analysis: Biologics Fill / Finish Service Providers in Europe
Figure 5.7 Company Competitiveness Analysis: Players Offering Services in Ampoules (Europe)
Figure 5.8 Company Competitiveness Analysis: Players Offering Services in Cartridges (Europe)
Figure 5.9 Company Competitiveness Analysis: Players Offering Services in Syringes (Europe)
Figure 5.10 Company Competitiveness Analysis: Players Offering Services in Vials (Europe)
Figure 5.11 Company Competitiveness Analysis: Biologics Fill / Finish Service Providers in (Asia-Pacific and Rest of the World)
Figure 5.12 Company Competitiveness Analysis: Players Offering Services in Ampoules (Asia-Pacific and Rest of the World)
Figure 5.13 Company Competitiveness Analysis: Players Offering Services in Cartridges (Asia-Pacific and Rest of World)
Figure 5.14 Company Competitiveness Analysis: Players Offering Services in Syringes (Asia-Pacific and Rest of the World)
Figure 5.15 Company Competitiveness Analysis: Players Offering Services in Vials (Asia-Pacific and Rest of the World)
Figure 6.1 AbbVie Contract Manufacturing: Overview of Service Portfolio
Figure 6.2 AbbVie: Annual Revenues, 2015-2020 (USD Billion)
Figure 6.3 BioPharma Solutions: Overview of Service Portfolio
Figure 6.4 BioReliance: Overview of Service Portfolio
Figure 6.5 Merck KGaA: Annual Revenues, 2014 - 9M 2020 (EUR Billion)
Figure 6.6 Merck KGaA: Annual Revenues by Business Segmnent, 9M 2020 (EUR Billion)
Figure 6.7 Catalent Biologics: Overview of Service Portfolio
Figure 6.8 Catalent Biologics: Annual Revenues, 2015-2020 (USD Billion)
Figure 6.9 Patheon: Overview of Service Portfolio
Figure 6.10 Thermo Fisher Scientific: Annual Revenues, 2014-9M 2020 (USD Billion)
Figure 7.1 Boehringer Ingelheim BioXcellence: Overview of Service Portfolio
Figure 7.2 Boehringer Ingelheim BioXcellence: Annual Revenues, 2014 - H1 2020 (EUR Billion)
Figure 7.3 Lonza: Overview of Service Portfolio
Figure 7.4 Lonza: Annual Revenues, 2014 - H1 2020 (CHF Million)
Figure 7.5 Pierre Fabre: Overview of Service Portfolio
Figure 7.6 Pierre Fabre: Annual Revenues, 2015 - 2019 (EUR Billion)
Figure 7.7 Recipharm: Overview of Service Portfolio
Figure 7.8 Recipharm: Annual Revenues, 2012 - 9M 2020 (SEK Billion)
Figure 7.9 Recipharm: Revenues by Business Divisions, 9M 2020 (SEK Billion)
Figure 7.10 Wacker Biotech: Overview of Service Portfolio
Figure 7.11 Wacker Chemie: Annual Revenues, 2015 - 2020 (EUR Billion)
Figure 8.1 Asymchem: Overview of Service Portfolio
Figure 8.2 Asymchem: Annual Revenues, 2015-2019 (USD Million)
Figure 8.3 ChemPartner: Overview of Service Portfolio
Figure 8.4 Samsung Biologics: Overview of Service Portfolio
Figure 8.5 Samsung Biologics: Annual Revenues, FY 2016 - FY 2020 (KRW Billion)
Figure 8.6 Syngene: Overview of Service Portfolio
Figure 8.7 Syngene: Annual Revenues, FY 2016 – Q3 FY 2021 (INR Million)
Figure 8.8 Takara Bio: Overview of Service Portfolio
Figure 8.9 Takara Bio: Annual Revenues, FY 2016 - H1 FY 2021 (JPY Billion)
Figure 8.10 WuXi Biologics: Overview of Service Portfolio
Figure 8.11 WuXi Biologics: Annual Revenues, 2014 - H1 2020 (RMB Million)
Figure 9.1 Partnerships and Collaborations: Cumulative Trend by Year, 2013-2020
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Scale of Operation
Figure 9.4 Partnerships and Collaborations: Distribution by Type of Service
Figure 9.5 Partnerships and Collaborations: Distribution by Types of Process
Figure 9.6 Partnerships and Collaborations: Distribution by Type of Biologic Involved and Type of Service Offered
Figure 9.7 Partnerships and Collaborations: Most Active Players
Figure 9.8 Partnerships and Collaborations: Geographical Analysis
Figure 9.9 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 9.10 Partnerships and Collaborations: Distribution by Geographical Location of Facilities
Figure 10.1 Recent Expansions: Distribution by Year of Expansion, 2013-2021 (till January)
Figure 10.2 Recent Expansions: Distribution by Type of Expansion
Figure 10.3 Recent Expansions: Distribution by Type of Packaging Form
Figure 10.4 Recent Expansions: Distribution by Type of Expansion and Type of Service
Figure 10.5 Recent Expansions: Distribution by Type of Biologic Involved
Figure 10.6 Recent Expansions: Distribution by Type of Biologic Involved and Scale of Operation
Figure 10.7 Recent Expansions: Distribution by Geographical Location
Figure 10.8 Recent Expansions: Most Active Players
Figure 10.9 Recent Expansions: Distribution by Location of Expansion Project
Figure 10.10 Recent Expansions in North America: Distribution by Type of Service Offered and Type of Biologic Involved
Figure 10.11 Recent Expansions in Europe: Distribution by Type of Service and Type of Biologic
Figure 10.12 Recent Expansions in Asia-Pacific: Distribution by Type of Service and Type of Biologic
Figure 11.1 Capacity for Filling Ampoules: Distribution by Company Size (Sample Data Set)
Figure 11.2 Capacity for Filling Cartridges: Distribution by Company Size (Sample Data Set)
Figure 11.3 Capacity for Filling Syringes: Distribution by Company Size (Sample Data Set)
Figure 11.4 Capacity for Filling Vials: Distribution by Company Size (Sample Data Set)
Figure 11.5 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Type of Packaging (Million Units)
Figure 11.6 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Company Size (Million Units)
Figure 11.7 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Scale of Operation (Million Units)
Figure 11.8 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Location of Headquarters (Million Units)
Figure 11.9 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Figure 11.10 Global Fill / Finish Capacity (by Fill Volume): Distribution by Type of Packaging (Kilo Liters)
Figure 11.11 Global Fill / Finish Capacity (by Fill Volume): Distribution by Company Size (Kilo Liters)
Figure 11.12 Global Fill / Finish Capacity (by Fill Volume): Distribution by Scale of Operation (Kilo Liters)
Figure 11.13 Global Fill / Finish Capacity (by Fill Volume): Distribution by Location of Headquarters (Kilo Liters)
Figure 11.14 Global Fill / Finish Capacity (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Kilo Liters)
Figure 11.15 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Figure 11.16 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Range of Capacity by Company Size
Figure 11.17 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Figure 11.18 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Figure 11.19 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Figure 11.20 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Company Size (Liters)
Figure 11.21 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Range of Capacity by Company Size (Liters)
Figure 11.22 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Scale of Operation (Liters)
Figure 11.23 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Location of Headquarters (Liters)
Figure 11.24 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Figure 11.25 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Figure 11.26 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Range of Capacity by Company Size
Figure 11.27 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Figure 11.28 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Figure 11.29 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Figure 11.30 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Company Size (Liters)
Figure 11.31 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Range of Capacity by Company Size (Liters)
Figure 11.32 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Scale of Operation (Liters)
Figure 11.33 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Location of Headquarters (Liters)
Figure 11.34 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Figure 11.35 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Range of Capacity by Company Size (Thousand Units)
Figure 11.36 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Range of Capacity by Company Size (Thousand Units)
Figure 11.37 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Figure 11.38 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Figure 11.39 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Figure 11.40 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Company Size (Liters)
Figure 11.41 Global Fill / Finish Capacity for Syringes (by Fill Volume): Range of Capacity by Company Size (Liters)
Figure 11.42 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Scale of Operation (Liters)
Figure 11.43 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Location of Headquarters (Liters)
Figure 11.44 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Figure 11.45 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Figure 11.46 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Range of Capacity by Company Size
Figure 11.47 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Figure 11.48 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Figure 11.49 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Figure 11.50 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Company Size (Kilo Liters)
Figure 11.51 Global Fill / Finish Capacity for Vials (by Fill Volume): Range of Capacity by Company Size (Kilo Liters)
Figure 11.52 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Scale of Operation (Kilo Liters)
Figure 11.53 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Location of Headquarters (Kilo Liters)
Figure 11.54 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Figure 12.1 Global Demand for Biologics Fill / Finish Services (Million Liters)
Figure 12.2 Global Demand for Biologics Fill / Finish Services: Distribution by Type of Packaging (Kilo Liters)
Figure 12.3 Global Demand for Biologics Fill / Finish Services: Distribution by Type of Biologic Involved (Kilo Liters)
Figure 12.4 Global Demand for Biologics Fill / Finish Services: Distribution by Therapeutic Area (Kilo Liters)
Figure 12.5 Global Demand for Biologics Fill / Finish Services: Distribution by Geographical Location (Kilo Liters)
Figure 12.6 Global Biologics Fill / Finish Services: Demand and Supply, 2021-2030
Figure 13.1 Biologics Manufacturing and Fill / Finish: Key Performance Indicators (KPIs)
Figure 13.2 Financial Indicators: Comparative Analysis of KPIs Considered by Big Pharma Companies
Figure 13.3 Financial Indicators: Big Pharma Perspective
Figure 13.4 Financial Indicators: Contract Manufacturers’ Perspective
Figure 13.5 Process / Capability-related Indicators: Comparative Analysis of KPIs of Big Pharma Companies
Figure 13.6 Process / Capability-related Indicators: Big Pharma Perspective
Figure 13.7 Process / Capability-related Indicators: Contract Manufacturers’ Perspective
Figure 13.8 Market Reputation-related Indicators: Comparative Analysis of KPIs of Big Pharma Companies
Figure 13.9 Market Reputation-related Indicators: Big Pharma Perspective
Figure 13.10 Market Reputation-related Indicators: Contract Manufacturers’ Perspective
Figure 13.11 Other Performance Indicators: Contract Manufacturers’ Perspective
Figure 14.1 Regional Capability Assessment: Biologic Fill / Finish Capabilities in North America
Figure 14.2 Regional Capability Assessment: Biologic Fill / Finish Capabilities in Europe
Figure 14.3 Regional Capability Assessment: Biologic Fill / Finish Capabilities in Asia-Pacific and Rest of the World
Figure 14.4 Regional Capability Assessment: Comparison of Capabilities across Different Regions
Figure 15.1 Overall Biologics Fill / Finish Services Market, 2021-2030 (USD Billion)
Figure 15.2 Biologics Fill / Finish Services Market, 2021-2030: Distribution by Type of Packaging (USD Million)
Figure 15.3 Biologics Fill / Finish Services Market, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.4 Biologics Fill / Finish Services Market, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.5 Biologics Fill / Finish Services Market, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.6 Biologics Fill / Finish Services Market, 2021-2030: Distribution by Geographical Region (USD Million)
Figure 15.7 Biologics Fill / Finish Services Market in North America, 2021-2030: Distribution by Countries (USD Million)
Figure 15.8 Biologics Fill / Finish Services Market in North America, 2021-2030: Distribution by Type of Packaging (USD Million)
Figure 15.9 Biologics Fill / Finish Services Market in North America, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.10 Biologics Fill / Finish Services Market in North America, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.11 Biologics Fill / Finish Services Market in North America, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.12 Biologics Fill / Finish Services Market in Europe, 2021-2030: Distribution by Countries (USD Million)
Figure 15.13 Biologics Fill / Finish Services Market in Europe, 2021-2030: Distribution by Type of Packaging (USD Million)
Figure 15.14 Biologics Fill / Finish Services Market in Europe, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.15 Biologics Fill / Finish Services Market in Europe, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.16 Biologics Fill / Finish Services Market in Europe, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.17 Biologics Fill / Finish Services Market in Asia-Pacific, 2021-2030: Distribution by Countries (USD Million)
Figure 15.18 Biologics Fill / Finish Services Market in Asia-Pacific, 2021-2030: Distribution by Type of Packaging (USD Million)
Figure 15.19 Biologics Fill / Finish Services Market in Asia-Pacific, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.20 Biologics Fill / Finish Services Market in Asia-Pacific, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.21 Biologics Fill / Finish Services Market in Asia-Pacific, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.22 Biologics Fill / Finish Services Market for Ampoules, 2021-2030 (USD Million)
Figure 15.23 Biologics Fill / Finish Services Market for Ampoules, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.24 Biologics Fill / Finish Services Market for Ampoules, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.25 Biologics Fill / Finish Services Market for Ampoules, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.26 Biologics Fill / Finish Services Market for Ampoules, 2021-2030: Distribution by Geographical Region (USD Million)
Figure 15.27 Biologics Fill / Finish Services Market for Ampoules in North America, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.28 Biologics Fill / Finish Services Market for Ampoules in North America, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.29 Biologics Fill / Finish Services Market for Ampoules in North America, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.30 Biologics Fill / Finish Services Market for Ampoules in Europe, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.31 Biologics Fill / Finish Services Market for Ampoules in Europe, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.32 Biologics Fill / Finish Services Market for Ampoules in Europe, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.33 Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.34 Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.35 Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.36 Biologics Fill / Finish Services Market for Cartridges, 2021-2030 (USD Million)
Figure 15.37 Biologics Fill / Finish Services Market for Cartridges, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.38 Biologics Fill / Finish Services Market for Cartridges, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.39 Biologics Fill / Finish Services Market for Cartridges, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.40 Biologics Fill / Finish Services Market for Cartridges, 2021-2030: Distribution by Geographical Region (USD Million)
Figure 15.41 Biologics Fill / Finish Services Market for Cartridges in North America, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.42 Biologics Fill / Finish Services Market for Cartridges in North America, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.43 Biologics Fill / Finish Services Market for Cartridges in North America, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.44 Biologics Fill / Finish Services Market for Cartridges in Europe, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.45 Biologics Fill / Finish Services Market for Cartridges in Europe, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.46 Biologics Fill / Finish Services Market for Cartridges in Europe, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.47 Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.48 Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.49 Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.50 Biologics Fill / Finish Services Market for Syringes, 2021-2030 (USD Million)
Figure 15.51 Biologics Fill / Finish Services Market for Syringes, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.52 Biologics Fill / Finish Services Market for Syringes, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.53 Biologics Fill / Finish Services Market for Syringes, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.54 Biologics Fill / Finish Services Market for Syringes, 2021-2030: Distribution by Geographical Region (USD Million)
Figure 15.55 Biologics Fill / Finish Services Market for Syringes in North America, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.56 Biologics Fill / Finish Services Market for Syringes in North America, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.57 Biologics Fill / Finish Services Market for Syringes in North America, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.58 Biologics Fill / Finish Services Market for Syringes in Europe, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.59 Biologics Fill / Finish Services Market for Syringes in Europe, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.60 Biologics Fill / Finish Services Market for Syringes in Europe, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.61 Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.62 Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.63 Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.64 Biologics Fill / Finish Services Market for Vials, 2021-2030 (USD Million)
Figure 15.65 Biologics Fill / Finish Services Market for Vials, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.66 Biologics Fill / Finish Services Market for Vials, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.67 Biologics Fill / Finish Services Market for Vials, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.68 Biologics Fill / Finish Services Market for Vials, 2021-2030: Distribution by Geographical Region (USD Million)
Figure 15.69 Biologics Fill / Finish Services Market for Vials in North America, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.70 Biologics Fill / Finish Services Market for Vials in North America, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.71 Biologics Fill / Finish Services Market for Vials in North America, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.72 Biologics Fill / Finish Services Market for Vials in Europe, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.73 Biologics Fill / Finish Services Market for Vials in Europe, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.74 Biologics Fill / Finish Services Market for Vials in Europe, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.75 Biologics Fill / Finish Services Market for Vials in Asia-Pacific, 2021-2030: Distribution by Scale of Operation (USD Million)
Figure 15.76 Biologics Fill / Finish Services Market for Vials in Asia-Pacific, 2021-2030: Distribution by Type of Biologic (USD Million)
Figure 15.77 Biologics Fill / Finish Services Market for Vials in Asia-Pacific, 2021-2030: Distribution by Therapeutic Area (USD Million)
Figure 16.1 Growth Opportunities for Biologics Fill / Finish Service Providers
Figure 16.2 New Molecular Entities Approved by the FDA, 2011-2020
Figure 17.1 Key Considerations for Selecting a Robotic System
Figure 17.2 Advantages of Robotic Systems in Pharmaceutical Operations
Figure 18.1 Key Drivers of Ready-to-Use Platform
Figure 19.1 Concluding Remarks: Current Biologic Fill / Finish Service Providers Market Landscape Summary
Figure 19.2 Concluding Remarks: Recent Partnerships
Figure 19.3 Concluding Remarks: Recent Expansions
Figure 19.4 Concluding Remarks: Capacity Analysis
Figure 19.5 Concluding Remarks: Demand Analysis
Figure 19.6 Concluding Remarks: Market Sizing and Opportunity Analysis for Biologic Fill / Finish Services Market
List Of Tables
Table 3.1 Best-Selling Drugs of 2019
Table 4.1 Biologics Fill / Finish Service Providers: List of Companies
Table 4.2 Biologics Fill / Finish Service Providers: Information on Type of Packaging
Table 4.3 Biologics Fill / Finish Service Providers: Information on Type of Biologic Involved
Table 4.4 Biologics Fill / Finish Service Providers: Information on Scale of Operation
Table 4.5 Biologics Fill / Finish Service Providers: Information on Additional Services Offered
Table 4.6 Biologics Fill / Finish Service Providers: Information on Fill / Finish Capacity
Table 6.1 Biologics Fill / Finish Service Providers in North America: List of Profiled Companies
Table 6.2 AbbVie Contract Manufacturing: Company Overview
Table 6.3 AbbVie Contract Manufacturing: Overview of Service Portfolio
Table 6.4 AbbVie Contract Manufacturing: Sterile Manufacturing Facilities
Table 6.5 AbbVie Contract Manufacturing: Recent Developments and Future Outlook
Table 6.6 BioPharma Solutions: Company Overview
Table 6.7 BioPharma Solutions: Overview of Service Portfolio
Table 6.8 BioPharma Solutions: Sterile Manufacturing Facilities
Table 6.9 BioPharma Solutions: Recent Developments and Future Outlook
Table 6.10 BioReliance: Company Overview
Table 6.11 BioReliance: Overview of Service Portfolio
Table 6.12 BioReliance: Sterile Manufacturing Facilities
Table 6.13 BioReliance: Recent Developments and Future Outlook
Table 6.14 Catalent Biologics: Company Overview
Table 6.15 Catalent Biologics: Overview of Service Portfolio
Table 6.16 Catalent Biologics: Sterile Manufacturing Facilities
Table 6.17 Catalent Biologics: Recent Developments and Future Outlook
Table 6.18 Patheon: Company Overview
Table 6.19 Patheon: Overview of Service Portfolio
Table 6.20 Patheon: Sterile Manufacturing Facilities
Table 6.21 Patheon: Recent Developments and Future Outlook
Table 7.1 Biologics Fill / Finish Service Providers in Europe: List of Profiled Companies
Table 7.2 Boehringer Ingelheim BioXcellence: Company Overview
Table 7.3 Boehringer Ingelheim BioXcellence: Overview of Service Portfolio
Table 7.4 Boehringer Ingelheim BioXcellence: Sterile Manufacturing Facilities
Table 7.5 Boehringer Ingelheim BioXcellence: Recent Developments and Future Outlook
Table 7.6 Lonza: Company Overview
Table 7.7 Lonza: Overview of Service Portfolio
Table 7.8 Lonza: Sterile Manufacturing Facilities
Table 7.9 Lonza: Recent Developments and Future Outlook
Table 7.10 Pierre Fabre: Company Overview
Table 7.11 Pierre Fabre: Overview of Service Portfolio
Table 7.12 Pierre Fabre: Sterile Manufacturing Facilities
Table 7.13 Pierre Fabre: Recent Developments and Future Outlook
Table 7.14 Recipharm: Company Overview
Table 7.15 Recipharm: Overview of Service Portfolio
Table 7.16 Recipharm: Sterile Manufacturing Facilities
Table 7.17 Recipharm: Recent Developments and Future Outlook
Table 7.18 Wacker Biotech: Company Overview
Table 7.19 Wacker Biotech: Overview of Service Portfolio
Table 7.20 Wacker Biotech: Sterile Manufacturing Facilities
Table 7.21 Wacker Biotech: Recent Developments and Future Outlook
Table 8.1 Biologics Fill / Finish Service Providers in Asia-Pacific: List of Profiled Companies
Table 8.2 Asymchem: Company Overview
Table 8.3 Asymchem: Overview of Service Portfolio
Table 8.4 Asymchem: Sterile Manufacturing Facilities
Table 8.5 Asymchem: Recent Developments and Future Outlook
Table 8.6 Syngene: Company Overview
Table 8.7 Syngene: Overview of Service Portfolio
Table 8.8 Syngene: Recent Developments and Future Outlook
Table 8.9 Takara Bio: Company Overview
Table 8.10 Takara Bio: Overview of Service Portfolio
Table 8.11 Takara Bio: Recent Developments and Future Outlook
Table 8.12 WuXi Biologics: Company Overview
Table 8.13 WuXi Biologics: Overview of Drug Product Services
Table 8.14 WuXi Biologics: Sterile Manufacturing Facilities
Table 8.15 WuXi Biologics: Recent Developments and Future Outlook
Table 9.1 Biologics Fill / Finish Service Providers: Partnerships and Collaborations, 2013-2020
Table 9.2 Partnerships and Collaborations: Information on Types of Services Offered, 2013-2020
Table 9.3 Partnerships and Collaborations: Information on Types of Biologics Involved, 2013-2020
Table 10.1 Biologics Fill / Finish Service Providers: Recent Expansions, 2013-2021 (till January)
Table 10.2 Recent Expansions, 2013-2021 (till January): Information on Type of Packaging
Table 10.3 Recent Expansions, 2013-2021 (till January): Information on Types of Services
Table 10.4 Recent Expansions, 2013-2021 (till January): Information on Types of Biologics
Table 11.1 Average Fill / Finish Capacity for Ampoules (Number of Units Filled) by Company Size (Sample Data Set)
Table 11.2 Average Fill / Finish Capacity for Cartridges (Number of Units Filled) by Company Size (Sample Data Set)
Table 11.3 Average Fill / Finish Capacity for Syringes (Number of Units Filled) by Company Size (Sample Data Set)
Table 11.4 Average Fill / Finish Capacity for Vials (Number of Units Filled) by Company Size (Sample Data Set)
Table 11.5 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Company Size
Table 11.6 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Company Size
Table 11.7 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Company Size
Table 11.8 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Company Size
Table 11.9 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Company Size
Table 11.10 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Company Size
Table 11.11 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Company Size
Table 11.12 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Company Size
Table 12.1 Global Biologics Fill / Finish Services: Annual Supply for Outsourcing, 2021-2030 (Million Liters)
Table 16.1 Patent Expiry of Biologics, 2021-2023
Table 17.1 Biologics Fill / Finish Service Providers: Information on Fill / Finish Equipment Used
Table 17.2 List of Pharmaceutical Robotics Manufacturers
Table 17.3 Isolator based Aseptic Filling Systems: Information on Compatible Primary Container
Table 18.1 List of Companies Supplying Ready-to-Use Packaging Components
Table 19.1 Biologics Fill / Finish Service Providers: Summary of the Report
Table 21.1 Biologics Fill / Finish Service Providers: Distribution by Year of Establishment
Table 21.2 Biologics Fill / Finish Service Providers: Distribution by Company Size
Table 21.3 Biologics Fill / Finish Service Providers: Distribution by Location of Headquarters
Table 21.4 Biologics Fill / Finish Service Providers: Distribution by Location of Fill / Finish Facilities
Table 21.5 Biologics Fill / Finish Service Providers: Distribution by Type of Packaging
Table 21.6 Biologics Fill / Finish Service Providers: Distribution by Type of Biologic Involved and Type of Packaging Form
Table 21.7 Biologics Fill / Finish Service Providers: Distribution by Scale of Operation
Table 21.8 Biologics Fill / Finish Service Providers: Distribution by Type of Additional Services Offered
Table 21.9 AbbVie: Annual Revenues, 2015 - 2020 (USD Billion)
Table 21.10 Merck KGaA: Annual Revenues, 2014 - 9M 2020 (EUR Billion)
Table 21.11 Merck KGaA: Annual Revenues by Business Segment, 9M 2020 (EUR Billion)
Table 21.12 Catalent Biologics: Annual Revenues, 2015 - 2020 (USD Billion)
Table 21.13 Thermo Fisher Scientific: Annual Revenues, 2014 - 9M 2020 (USD Billion)
Table 21.14 Patheon: Annual Revenues, 2012 - H1 2017 (USD Million)
Table 21.15 Boehringer Ingelheim BioXcellence: Overview of Service Portfolio
Table 21.16 Boehringer Ingelheim BioXcellence: Annual Revenues, 2014 - H1 2020 (EUR Billion)
Table 21.17 Lonza: Annual Revenues, 2014 - H1 2020 (CHF Million)
Table 21.18 Pierre Fabre: Annual Revenues, 2015 - 2018 (EUR Billion)
Table 21.19 Recipharm: Annual Revenues, 2012 - 9M 2020 (SEK Billion)
Table 21.20 Recipharm: Revenues by Business Divisions, 9M 2020 (SEK Billion)
Table 21.21 Wacker Chemie: Annual Revenues, 2015 - 2020 (EUR Billion)
Table 21.22 Asymchem: Annual Revenues, 2015 - 2019 (USD Million)
Table 21.23 Samsung Biologics: Annual Revenues, FY 2016 - FY 2020 (KRW Billion)
Table 21.24 Syngene: Annual Revenues, FY 2016 - 9M FY 2021 (INR Million)
Table 21.25 Takara Bio: Annual Revenues, FY 2016 - H1 FY 2021 (JPY Billion)
Table 21.26 WuXi Biologics: Annual Revenues, 2014 - H1 2020 (RMB Million)
Table 21.27 Partnerships and Collaborations: Cumulative Year-wise Trend, 2013-2020
Table 21.28 Partnerships and Collaborations: Distribution by Type of Partnership
Table 21.29 Partnerships and Collaborations: Distribution by Scale of Operation
Table 21.30 Partnerships and Collaborations: Distribution by Types of Services Offered
Table 21.31 Partnerships and Collaborations: Distribution by Types of Processes
Table 21.32 Partnerships and Collaborations: Distribution by Types of Biologics Involved and Type of Services Offered
Table 21.33 Partnerships and Collaborations: Most Active Players
Table 21.34 Partnerships and Collaborations: Geographical Analysis
Table 21.35 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 21.36 Partnerships and Collaborations: Distribution by Geographical Location of Facilities
Table 21.37 Recent Expansions: Distribution by Year of Expansion, 2013-2021 (till January)
Table 21.38 Recent Expansions: Distribution by Type of Expansion
Table 21.39 Recent Expansions: Distribution by Type of Packaging
Table 21.40 Recent Expansions: Distribution by Type of Expansion and Type of Service
Table 21.41 Recent Expansions: Distribution by Type of Biologic Involved
Table 21.42 Recent Expansions: Distribution by Type of Biologic and Scale of Operation
Table 21.43 Recent Expansions: Distribution by Geographical Location
Table 21.44 Recent Expansions: Distribution by Most Active Players
Table 21.45 Recent Expansions: Distribution by Location of Expansion Project
Table 21.46 Recent Expansions in North America: Distribution by Type of Service Offered and Type of Biologic Involved
Table 21.47 Recent Expansions in Europe: Distribution by Type of Service and Type of Biologic
Table 21.48 Recent Expansions in Asia-Pacific: Distribution by Type of Service and Type of Biologic
Table 21.49 Capacity for Filling Ampoules: Distribution by Company Size (Sample Data Set)
Table 21.50 Capacity for Filling Cartridges: Distribution by Company Size (Sample Data Set)
Table 21.51 Capacity for Filling Syringes: Distribution by Company Size (Sample Data Set)
Table 21.52 Capacity for Filling Vials: Distribution by Company Size (Sample Data Set)
Table 21.53 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Type of Packaging (Million Units)
Table 21.54 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Company Size (Million Units)
Table 21.55 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Scale of Operation (Million Units)
Table 21.56 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Location of Headquarters (Million Units)
Table 21.57 Global Fill / Finish Capacity (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Table 21.58 Global Fill / Finish Capacity (by Fill Volume): Distribution by Type of Packaging (Kilo Liters)
Table 21.59 Global Fill / Finish Capacity (by Fill Volume): Distribution by Company Size (Kilo Liters)
Table 21.60 Global Fill / Finish Capacity (by Fill Volume): Distribution by Scale of Operation (Kilo Liters)
Table 21.61 Global Fill / Finish Capacity (by Fill Volume): Distribution by Location of Headquarters (Kilo Liters)
Table 21.62 Global Fill / Finish Capacity (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Kilo Liters)
Table 21.63 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Table 21.64 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Table 21.65 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Table 21.66 Global Fill / Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Table 21.67 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Company Size (Liters)
Table 21.68 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Scale of Operation (Liters)
Table 21.69 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Location of Headquarters (Liters)
Table 21.70 Global Fill / Finish Capacity for Ampoules (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Table 21.71 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Table 21.72 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Table 21.73 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Table 21.74 Global Fill / Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Table 21.75 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Company Size (Liters)
Table 21.76 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Scale of Operation (Liters)
Table 21.77 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Location of Headquarters (Liters)
Table 21.78 Global Fill / Finish Capacity for Cartridges (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Table 21.79 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Company Size
Table 21.80 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Table 21.81 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Table 21.82 Global Fill / Finish Capacity for Syringes (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Table 21.83 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Company Size (Liters)
Table 21.84 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Scale of Operation (Liters)
Table 21.85 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Location of Headquarters (Liters)
Table 21.86 Global Fill / Finish Capacity for Syringes (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Table 21.87 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Table 21.88 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Table 21.89 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Table 21.90 Global Fill / Finish Capacity for Vials (by Number of Units Filled): Distribution by Location of Fill / Finish Facilities (Thousand Units)
Table 21.91 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Company Size (Liters)
Table 21.92 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Scale of Operation (Liters)
Table 21.93 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Location of Headquarters (Liters)
Table 21.94 Global Fill / Finish Capacity for Vials (by Fill Volume): Distribution by Location of Fill / Finish Facilities (Liters)
Table 21.95 Global Demand for Biologics Fill / Finish Services (Million Liters)
Table 21.96 Global Demand for Biologics Fill / Finish Services: Distribution by Type of Packaging (Kilo Liters)
Table 21.97 Global Demand for Biologics Fill / Finish Services: Distribution by Type of Biologic (Kilo Liters)
Table 21.98 Global Demand for Biologics Fill / Finish Services: Distribution by Therapeutic Area (Kilo Liters)
Table 21.99 Global Demand for Biologics Fill / Finish Services: Distribution by Geographical Location (Kilo Liters)
Table 21.100 Global Biologics Fill / Finish Services: Demand and Supply, 2021-2030
Table 21.101 Overall Biologics Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2021-2030 (USD Billion)
Table 21.102 Biologics Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Packaging (USD Million)
Table 21.103 Biologics Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.104 Biologics Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.105 Biologics Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.106 Biologics Fill / Finish Services Market, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Geographical Region (USD Million)
Table 21.107 Biologics Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Countries (USD Million)
Table 21.108 Biologics Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Packaging (USD Million)
Table 21.109 Biologics Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.110 Biologics Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.111 Biologics Fill / Finish Services Market in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.112 Biologics Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Countries (USD Million)
Table 21.113 Biologics Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Packaging (USD Million)
Table 21.114 Biologics Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.115 Biologics Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.116 Biologics Fill / Finish Services Market in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.117 Biologics Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Countries (USD Million)
Table 21.118 Biologics Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Packaging (USD Million)
Table 21.119 Biologics Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.120 Biologics Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.121 Biologics Fill / Finish Services Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.122 Biologics Fill / Finish Services Market for Ampoules, Conservative, Base and Optimistic Scenario, 2021-2030 (USD Million)
Table 21.123 Biologics Fill / Finish Services Market for Ampoules, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.124 Biologics Fill / Finish Services Market for Ampoules, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.125 Biologics Fill / Finish Services Market for Ampoules, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.126 Biologics Fill / Finish Services Market for Ampoules, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Geographical Region (USD Million)
Table 21.127 Biologics Fill / Finish Services Market for Ampoules in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.128 Biologics Fill / Finish Services Market for Ampoules in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.129 Biologics Fill / Finish Services Market for Ampoules in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.130 Biologics Fill / Finish Services Market for Ampoules in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.131 Biologics Fill / Finish Services Market for Ampoules in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.132 Biologics Fill / Finish Services Market for Ampoules in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.133 Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.134 Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.135 Biologics Fill / Finish Services Market for Ampoules in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.136 Biologics Fill / Finish Services Market for Cartridges, Conservative, Base and Optimistic Scenario, 2021-2030 (USD Million)
Table 21.137 Biologics Fill / Finish Services Market for Cartridges, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.138 Biologics Fill / Finish Services Market for Cartridges, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.139 Biologics Fill / Finish Services Market for Cartridges, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.140 Biologics Fill / Finish Services Market for Cartridges, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Geographical Region (USD Million)
Table 21.141 Biologics Fill / Finish Services Market for Cartridges in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.142 Biologics Fill / Finish Services Market for Cartridges in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.143 Biologics Fill / Finish Services Market for Cartridges in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.144 Biologics Fill / Finish Services Market for Cartridges in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.145 Biologics Fill / Finish Services Market for Cartridges in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.146 Biologics Fill / Finish Services Market for Cartridges in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.147 Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.148 Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.149 Biologics Fill / Finish Services Market for Cartridges in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.150 Biologics Fill / Finish Services Market for Syringes, Conservative, Base and Optimistic Scenario, 2021-2030 (USD Million)
Table 21.151 Biologics Fill / Finish Services Market for Syringes, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.152 Biologics Fill / Finish Services Market for Syringes, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.153 Biologics Fill / Finish Services Market for Syringes, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.154 Biologics Fill / Finish Services Market for Syringes, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Geographical Region (USD Million)
Table 21.155 Biologics Fill / Finish Services Market for Syringes in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.156 Biologics Fill / Finish Services Market for Syringes in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.157 Biologics Fill / Finish Services Market for Syringes in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.158 Biologics Fill / Finish Services Market for Syringes in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.159 Biologics Fill / Finish Services Market for Syringes in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.160 Biologics Fill / Finish Services Market for Syringes in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.161 Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.162 Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.163 Biologics Fill / Finish Services Market for Syringes in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.164 Biologics Fill / Finish Services Market for Vials, Conservative, Base and Optimistic Scenario, 2021-2030 (USD Million)
Table 21.165 Biologics Fill / Finish Services Market for Vials, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.166 Biologics Fill / Finish Services Market for Vials, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.167 Biologics Fill / Finish Services Market for Vials, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.168 Biologics Fill / Finish Services Market for Vials, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Geographical Region (USD Million)
Table 21.169 Biologics Fill / Finish Services Market for Vials in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.170 Biologics Fill / Finish Services Market for Vials in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.171 Biologics Fill / Finish Services Market for Vials in North America, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.172 Biologics Fill / Finish Services Market for Vials in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.173 Biologics Fill / Finish Services Market for Vials in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.174 Biologics Fill / Finish Services Market for Vials in Europe, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.175 Biologics Fill / Finish Services Market for Vials in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Scale of Operation (USD Million)
Table 21.176 Biologics Fill / Finish Services Market for Vials in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Type of Biologic (USD Million)
Table 21.177 Biologics Fill / Finish Services Market for Vials in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2030: Distribution by Therapeutic Area (USD Million)
Table 21.178 New Molecular Entities Approved by the FDA, 2011-2020